Provided by Tiger Trade Technology Pte. Ltd.

SIHUAN PHARM

0.750
-0.030-3.85%
Volume:80.12M
Turnover:60.29M
Market Cap:6.84B
PE:32.64
High:0.775
Open:0.775
Low:0.740
Close:0.780
52wk High:1.896
52wk Low:0.740
Shares:9.12B
HK Float Shares:9.12B
Volume Ratio:1.11
T/O Rate:0.88%
Dividend:0.02
Dividend Rate:2.91%
EPS(LYR):0.023
ROE:5.57%
ROA:2.73%
PB:0.95
PE(LYR):32.64
PS:2.23

Loading ...

Xuanzhu says Phase 1b NG-350A plus chemoradiotherapy hits 50% composite response rate

Reuters
·
Apr 20

Sihuan Pharma - Dirozalkib Shows Significant Efficacy Advantages in First-Line Alk-Positive Advanced Nsclc

THOMSON REUTERS
·
Apr 20

Sihuan Pharma - Xuanzhu Biopharm Presents Phase Iii Dirozalkib Data for Alk-Positive Nsclc at 2026 Aacr

THOMSON REUTERS
·
Apr 20

Xuanzhu says Phase III trial shows dirozalkib cuts lung cancer progression risk 53%

Reuters
·
Apr 19

Xuanzhu Biopharma wins HKEX approval to list 357,245,794 converted H shares

Reuters
·
Apr 17

Sihuan Pharm’s Xuanzhu Biopharm Secures CDE Approval for Phase III Trial of Anaprazole Sodium in Helicobacter Pylori Eradication

Bulletin Express
·
Apr 15

BUZZ-Xuanzhu Biopharmaceutical climbs to three-week high on approval for drug clinical trial

Reuters
·
Apr 15

Xuanzhu Biopharma wins China CDE nod for Phase III Anaprazole H. pylori trial

Reuters
·
Apr 15

BUZZ-China's Xuanzhu set for best day in 6 months on drug deal with Boston Oncology

Reuters
·
Apr 10

SIHUAN PHARM Subsidiary Xuanzhu Biopharm Inks >US$100 Million Licensing & Supply Deal with Boston Oncology for Breast and Lung Cancer Drugs in MENA

Bulletin Express
·
Apr 09

BRIEF-Xuanzhu Biopharmaceutical Enters Licensing Agreement With Boston Oncology

Reuters
·
Apr 09

Xuanzhu Biopharm licenses breast cancer, lung cancer drugs to Boston Oncology in MENA deal

Reuters
·
Apr 09

Biocytogen-B Shares Extend Rally with Over 6% Gain on AI-Driven Obesity Drug Partnership

Stock News
·
Apr 02

Hong Kong Stock Announcement Highlights | Biocytogen-B and Sihuan Pharmaceutical Form Strategic Partnership to Accelerate Innovative Drug Development in Weight Loss and Other Areas

Stock News
·
Apr 02

IEA Warns of Doubling Oil Supply Gap in April; US Launches Manned Moon Mission Rocket

Stock News
·
Apr 02

Asian Penny Stocks Under US$10B Market Cap: 3 Picks To Consider

Simply Wall St.
·
Apr 02

Assessing Sihuan Pharmaceutical Holdings Group’s Valuation After Earnings Turnaround And Positive Bireociclib Phase 3 Results

Simply Wall St.
·
Apr 01

BRIEF-Sihuan Pharma Signs Strategic Collaboration With Biocytogen For AI-Driven Drug R&D

Reuters
·
Apr 01

SIHUAN PHARM and BIOCYTOGEN-B Forge Strategic Alliance to Accelerate Innovative Drug Development in Weight Loss and Other Areas Using AI-Powered Human Antibody Platform

Stock News
·
Apr 01

Sihuan Pharm partners with Biocytogen to accelerate AI-driven fully human antibody R&D for next-gen weight-loss therapy

Bulletin Express
·
Apr 01